Skip to main content
Top
Metadata
Title
The Clinical Management of Chondrosarcoma
Authors
Richard F. Riedel, MD
Nicole Larrier, MD
Leslie Dodd, MD
David Kirsch, MD, PhD
Salutario Martinez, MD
Brian E. Brigman, MD, PhD
Publication date
01-04-2009
Publisher
Springer US
Published in
Current Treatment Options in Oncology / Issue 1-2/2009
Print ISSN: 1527-2729
Electronic ISSN: 1534-6277
DOI
https://doi.org/10.1007/s11864-009-0088-2

Other articles of this Issue 1-2/2009

Current Treatment Options in Oncology 1-2/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine